↵ Bygdaman M . Termination of second trimester pregnancy with laminaria and intramuscular 15-methyl PGF2 alpha or 16-phenoxy-omega-17,18,19,20-tetranor PGE2 methyl sulfonylamide. A randomized multicenter study. Int J Gynaecol Obstet 1988;26:129–135.CrossRefPubMedGoogle Scholar
↵ Cameron IT , Michie AF , Baird DT . Prostaglandin-induced pregnancy termination: further studies using gemeprost (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) vaginal pessaries in the early second trimester. Prostaglandins 1987;34:111–117.doi:10.1016/0090-6980(87)90268-1 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Weeks A , Faúndes A . Misoprostol in obstetrics and gynecology. Int J Gynaecol Obstet 2007;99:S156–S159.doi:10.1016/j.ijgo.2007.09.003 PubMedGoogle Scholar
↵ Lalitkumar S , Bygdeman M , Gemzell-Danielsson K . Mid-trimester induced abortion: a review. Hum Reprod Update 2007;13:37–52.doi:10.1093/humupd/dml049 CrossRefPubMedGoogle Scholar
↵ Shaw D . Misoprostol for reproductive health: dosage recommendations. Int J Gynaecol Obstet 2007;99:S155.doi:10.1016/j.ijgo.2007.09.002 Google Scholar
↵ Wildschut H , Both MI , Medema S , et al . Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev 2011;1:CD005216.PubMedGoogle Scholar
↵ Wong KS , Ngai CS , Wong AY , et al . Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. Contraception 1998;58:207–210.doi:10.1016/S0010-7824(98)00099-7 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Gómez Ponce de León R , Wing DA . Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review. Contraception 2009;79:259–271.doi:10.1016/j.contraception.2008.10.009 Google Scholar
↵ Nigam A , Singh VK , Prakash A . Vaginal vs. oral misoprostol for mid-trimester abortion. Int J Gynaecol Obstet 2006;92:270–271.doi:10.1016/j.ijgo.2005.11.010 PubMedGoogle Scholar
↵ Tang OS , Gemzell-Danielsson K , Ho PC . Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007;99:S160–S167.doi:10.1016/j.ijgo.2007.09.004 CrossRefPubMedGoogle Scholar
↵ Goldberg AB , Greenberg MB , Darney PD . Misoprostol and pregnancy. N Engl J Med 2001;344:38–47.doi:10.1056/NEJM200101043440107 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Nijman TA , Voogdt KG , Teunissen PW , et al . Association between infection and fever in terminations of pregnancy using misoprostol: a retrospective cohort study. BMC Pregnancy Childbirth 2017;17:7.doi:10.1186/s12884-016-1188-1 Google Scholar
↵ Su LL , Biswas A , Choolani M , et al . A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy. Am J Obstet Gynecol 2005;193:1410–1414.doi:10.1016/j.ajog.2005.02.082 PubMedGoogle Scholar
↵ Allen R , O’Brien BM . Uses of misoprostol in obstetrics and gynecology. Rev Obstet Gynecol 2009;2:159–68.PubMedGoogle Scholar
↵ Dickinson JE , Godfrey M , Evans SF . Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. J Matern Fetal Med 1998;7:115–119.doi:10.1002/(SICI)1520-6661(199805/06)7:3<115::AID-MFM3>3.0.CO;2-N CrossRefPubMedGoogle Scholar
↵ Tang OS , Lau WN , Chan CC , et al . A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG 2004;111:1001–1005.doi:10.1111/j.1471-0528.2004.00222.x CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Wong KS , Ngai CS , Yeo EL , et al . A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000;15:709–712.doi:10.1093/humrep/15.3.709 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Nuutila M , Toivonen J , Ylikorkala O , et al . A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstet Gynecol 1997;90:896–900.doi:10.1016/S0029-7844(97)00491-2 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Zieman M , Fong SK , Benowitz NL , et al . Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88–92.doi:10.1016/S0029-7844(97)00111-7 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Dickinson JE , Evans SF . The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002;186:470–474.doi:10.1067/mob.2002.121085 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Kapp N , Borgatta L , Stubblefield P , et al . Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol 2007;110:1304–1310.doi:10.1097/01.AOG.0000289577.32274.a5 CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Ngoc NT , Shochet T , Raghavan S , et al . Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol 2011;118:601–608.doi:10.1097/AOG.0b013e318227214e CrossRefPubMedWeb of ScienceGoogle Scholar
↵ Goyal V . Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review. Obstet Gynecol 2009;113:1117–1123.doi:10.1097/AOG.0b013e31819dbfe2 PubMedWeb of ScienceGoogle Scholar